Literature DB >> 112871

Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.

J M Gerrard, S E Kindom, D A Peterson, J Peller, K E Krantz, J G White.   

Abstract

Decanoyl-, palmitoyl-, and oleoyl-lysophosphatidic acid (LPA) were studied for their effects on platelet aggregation and intracellular calcium flux. Palmitoyl-LPA and oleoyl-LPA both caused a concentration-dependent aggregation of human blood platelets at concentrations of 12--300 microM. Aggregation by adenosine diphosphate (ADP) was enhanced at slightly lower concentrations. First-wave aggregation induced by these LPAs was not blocked by aspirin, indomethacin, or heparin, suggesting similarities to ADP aggregation. However, in washed platelets with a high calcium concentration, no serotonin secretion was observed, even though full aggregation occurred, suggesting that aggregation was not due to released ADP. This concept was supported by studies of platelets deficient in the storage pool of ADP and serotonin, which had a normal first-wave aggregation response to palmitoyl-LPA. Aggregation induced by palmitoyl LPA was inhibited by prostaglandin E1 (PGE1), theophylline, and ethylenediaminotetraacetate (EDTA), though in the presence of EDTA shape change occurred. Aggregation stimulated by palmitoyl-LPA or oleoyl-LPA was characterized by changes in the shape of the platelets with development of pseudopods and centralization of granules closely surrounded by contractile microfilaments and supporting microtubules. The addition of palmitoyl-LPA and oleoyl-LPA, but not decanoyl-LPA, caused the release of calcium from a platelet membrane fraction that contains elements of the intracellular calcium storage system and actively concentrates this cation in the presence of adenosine triphosphate (ATP) and magnesium. It is suggested that LPAs cause aggregation by stimulating the release of calcium intracellularly.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112871      PMCID: PMC2042446     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Functional activity in glands and synaptic tissue and the turnover of phosphatidylinositol.

Authors:  L E Hokin
Journal:  Ann N Y Acad Sci       Date:  1969-10-17       Impact factor: 5.691

3.  Platelet aggregation and increased pulmonary vascular resistance in cats induced by DAS and ADP.

Authors:  K A Schumacher; H G Classen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Partial purification and properties of glycerophosphate acyltransferase from rat liver. Formation of 1-acylglycerol 3-phosphate from sn-glycerol 3-phosphate and palmityl coenzyme A.

Authors:  S Yamashita; S Numa
Journal:  Eur J Biochem       Date:  1972-12-18

Review 5.  The structure and function of platelets, with emphasis on their contractile nature.

Authors:  J M Gerrard; J G White
Journal:  Pathobiol Annu       Date:  1976

6.  Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase.

Authors:  R Käser-Glanzmann; M Jakäbovä; J N George; E F Lüscher
Journal:  Biochim Biophys Acta       Date:  1977-05-02

7.  Cyclic AMP and platelet prostaglandin synthesis.

Authors:  J M Gerrard; J D Peller; T P Krick; J G White
Journal:  Prostaglandins       Date:  1977-07

8.  Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.

Authors:  J G White; G H Rao; J M Gerrard
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

9.  Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro.

Authors:  J M Gerrard; A M Butler; G Graff; S F Stoddard; J G White
Journal:  Prostaglandins Med       Date:  1978-11

10.  Calcium uptake and associated adenosine triphosphatase activity of isolated platelet membranes.

Authors:  L S Robblee; D Shepro; F A Belamarich
Journal:  J Gen Physiol       Date:  1973-04       Impact factor: 4.086

View more
  30 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 2.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

3.  Lysophosphatidic acid and cardiovascular disease: seeing is believing.

Authors:  Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2013-03-18       Impact factor: 5.922

4.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

5.  Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.

Authors:  J M Gerrard; S E Kindom; D A Peterson; J G White
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

6.  Lysophosphatidic acid stimulates glucose transport in Xenopus oocytes via a phosphatidylinositol 3'-kinase with distinct properties.

Authors:  F J Thomson; C Moyes; P H Scott; R Plevin; G W Gould
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

7.  Acetal phosphatidic acids: novel platelet aggregating agents.

Authors:  J P Brammer; M H Maguire; E J Walaszek; R A Wiley
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

Review 8.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

9.  Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets.

Authors:  D E MacIntyre; W K Pollock
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

10.  Receptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activation.

Authors:  Zhi-Bin Zhou; Jian-Ping Niu; Zhi-Jun Zhang
Journal:  Int J Mol Sci       Date:  2009-07-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.